177 related articles for article (PubMed ID: 8957154)
1. The management of malignant hypercalcaemia.
Watters J; Gerrand G; Dodwell D
Drugs; 1996 Dec; 52(6):837-48. PubMed ID: 8957154
[TBL] [Abstract][Full Text] [Related]
2. Comparative tolerability of drug therapies for hypercalcaemia of malignancy.
Zojer N; Keck AV; Pecherstorfer M
Drug Saf; 1999 Nov; 21(5):389-406. PubMed ID: 10554053
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of calcitonin and clodronate in hypercalcaemia.
Ljunghall S; Rastad J; Akerström G
Bone; 1987; 8 Suppl 1():S79-83. PubMed ID: 2961359
[TBL] [Abstract][Full Text] [Related]
4. Modern management of malignant hypercalcemia.
Legrand SB
Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
[TBL] [Abstract][Full Text] [Related]
5. Pamidronate (Aredia, Ciba) in malignant hypercalcaemia.
MacConnachie AM
Intensive Crit Care Nurs; 1997 Feb; 13(1):58-9. PubMed ID: 9095884
[TBL] [Abstract][Full Text] [Related]
6. Medical management of hypercalcaemia.
Ralston SH
Br J Clin Pharmacol; 1992 Jul; 34(1):11-20. PubMed ID: 1633063
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
Williams CJ; Smith RA; Ball RJ; Wilkinson H
Arch Dis Child; 1997 Feb; 76(2):169-70. PubMed ID: 9068314
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and management of cancer associated hypercalcaemia.
Ralston SH
Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
[TBL] [Abstract][Full Text] [Related]
9. [Medical treatment of malignant hypercalcemia].
Eto S; Nakano Y; Okada Y
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
Ralston SH; Alzaid AA; Gardner MD; Boyle IT
Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
[TBL] [Abstract][Full Text] [Related]
11. [The pharmacology of biphosphonates and their use in hypercalcemia].
Adam Z; Vorlícek J; Tomíska M
Vnitr Lek; 1994 Oct; 40(10):667-70. PubMed ID: 7810087
[TBL] [Abstract][Full Text] [Related]
12. The management of hypercalcaemia in advanced cancer.
Pettifer A; Grant S
Int J Palliat Nurs; 2013 Jul; 19(7):327-31. PubMed ID: 24273809
[TBL] [Abstract][Full Text] [Related]
13. Current management strategies for hypercalcemia.
Pecherstorfer M; Brenner K; Zojer N
Treat Endocrinol; 2003; 2(4):273-92. PubMed ID: 15966562
[TBL] [Abstract][Full Text] [Related]
14. Use of bisphosphonates in hypercalcaemia due to malignancy.
Ralston SH; Gallacher SJ; Patel U; Fraser WD; Dryburgh FJ; Boyle IT
Lancet; 1990 Mar; 335(8691):737. PubMed ID: 1969100
[No Abstract] [Full Text] [Related]
15. Treatment of hypercalcaemia of malignancy.
Heath DA
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):139-45. PubMed ID: 2143893
[TBL] [Abstract][Full Text] [Related]
16. Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.
Heatley S
Int J Palliat Nurs; 2001 Jun; 7(6):301-2, 304-7. PubMed ID: 12066026
[TBL] [Abstract][Full Text] [Related]
17. Malignant osteopetrosis: hypercalcaemia after bone marrow transplantation.
Rawlinson PS; Green RH; Coggins AM; Boyle IT; Gibson BE
Arch Dis Child; 1991 May; 66(5):638-9. PubMed ID: 2039258
[TBL] [Abstract][Full Text] [Related]
18. Treatment of malignant hypercalcaemia.
Hurtado J; Esbrit P
Expert Opin Pharmacother; 2002 May; 3(5):521-7. PubMed ID: 11996631
[TBL] [Abstract][Full Text] [Related]
19. Treatment of bisphosphonate-resistant hypercalcemia of malignancy with calcitonin.
Dawson C; Todd AM; Walton A
J Palliat Med; 2014 Oct; 17(10):1084. PubMed ID: 25265187
[No Abstract] [Full Text] [Related]
20. Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
Kutluk MT; Hazar V; Akyüz C; Varan A; Büyükpamukçu M
J Pediatr; 1997 May; 130(5):828-31. PubMed ID: 9152297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
